These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32755257)

  • 1. An Unusual Case of Drug-Induced Thrombocytopenia.
    Wang S; Sawalha K; Khan A
    J Investig Med High Impact Case Rep; 2020; 8():2324709620947891. PubMed ID: 32755257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
    Ciccone A; Motto C; Abraha I; Cozzolino F; Santilli I
    Cochrane Database Syst Rev; 2014 Mar; (3):CD005208. PubMed ID: 24609741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases.
    Abdeladim S; Elharras M; Elouarradi A; Bensahi I; Oualim S; Merzouk F; Sabry M
    Pan Afr Med J; 2021; 38():9. PubMed ID: 33520078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.
    Bougie DW; Wilker PR; Wuitschick ED; Curtis BR; Malik M; Levine S; Lind RN; Pereira J; Aster RH
    Blood; 2002 Sep; 100(6):2071-6. PubMed ID: 12200368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial).
    Bonz AW; Lengenfelder B; Strotmann J; Held S; Turschner O; Harre K; Wacker C; Waller C; Kochsiek N; Meesmann M; Neyses L; Schanzenbächer P; Ertl G; Voelker W
    J Am Coll Cardiol; 2002 Aug; 40(4):662-8. PubMed ID: 12204495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tirofiban-induced thrombocytopenia.
    Wang J; Zou D
    Ann Med; 2023 Dec; 55(1):2233425. PubMed ID: 37439782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: reuse of tirofiban leads to very severe thrombocytopenia.
    Li Y; Qiu J; Gao Y; Li G
    Front Cardiovasc Med; 2023; 10():1130552. PubMed ID: 37273872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET).
    Chan AW; Moliterno DJ; Berger PB; Stone GW; DiBattiste PM; Yakubov SL; Sapp SK; Wolski K; Bhatt DL; Topol EJ;
    J Am Coll Cardiol; 2003 Oct; 42(7):1188-95. PubMed ID: 14522478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanishing platelets: rapid and extreme tirofiban-induced thrombocytopenia after percutaneous coronary intervention for acute myocardial infarction.
    Rahman N; Jafary FH
    Tex Heart Inst J; 2010; 37(1):109-12. PubMed ID: 20200641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.
    Alexander JH; Harrington RA
    Drugs; 1998 Dec; 56(6):965-76. PubMed ID: 9878986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding thrombocytopenia and antigenicity with glycoprotein IIb-IIIa inhibitors.
    Madan M; Berkowitz SD
    Am Heart J; 1999 Oct; 138(4 Pt 2):317-26. PubMed ID: 10502237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
    Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
    N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
    Dyke CM
    Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Cangrelor as a Bridge to Left Ventricular Assist Device Implantation in a Patient with a Recent Drug-Eluting Stent Who Developed Acute Tirofiban-Related Thrombocytopenia.
    Kabadi RA; Danelich IM; Entwistle JW; Marhefka GD; Reeves G; Boyle AJ; Qureshi AM
    Pharmacotherapy; 2019 Apr; 39(4):521-525. PubMed ID: 30644585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
    Peter K; Straub A; Kohler B; Volkmann M; Schwarz M; Kübler W; Bode C
    Am J Cardiol; 1999 Sep; 84(5):519-24. PubMed ID: 10482148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report.
    Wang ZM; Wang B; Li YF; Chen B; Shen Q; Li DF; Wang LS
    J Med Case Rep; 2023 Oct; 17(1):430. PubMed ID: 37838704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet glycoprotein IIb/IIIa inhibitors.
    Rosove MH
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):65-76. PubMed ID: 15171958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.
    De Luca G; Savonitto S; van't Hof AW; Suryapranata H
    Drugs; 2015 Jul; 75(11):1229-53. PubMed ID: 26177890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
    Xia JG; Qu Y; Shen H; Liu XH
    Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.